A. Robinson

3.3k total citations
35 papers, 764 citations indexed

About

A. Robinson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, A. Robinson has authored 35 papers receiving a total of 764 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in A. Robinson's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (5 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). A. Robinson is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (5 papers) and Radiopharmaceutical Chemistry and Applications (2 papers). A. Robinson collaborates with scholars based in United Kingdom, Ireland and Denmark. A. Robinson's co-authors include Martin Lee, John Dewar, S. Bowden, Daniel Rea, Robert Grieve, J. J. Nicoll, Christopher Poole, Richard Gray, Andrea Marshall and Kelly Handley and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

A. Robinson

34 papers receiving 744 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Robinson United Kingdom 12 393 332 241 222 126 35 764
Matthias Geberth Germany 11 437 1.1× 302 0.9× 232 1.0× 239 1.1× 64 0.5× 24 730
F Hofbauer Austria 11 456 1.2× 378 1.1× 276 1.1× 212 1.0× 237 1.9× 22 840
D F Hayes United States 8 464 1.2× 329 1.0× 152 0.6× 234 1.1× 89 0.7× 12 765
I. D. Werner South Africa 11 454 1.2× 473 1.4× 239 1.0× 146 0.7× 254 2.0× 16 1.0k
C. Parsons United Kingdom 14 377 1.0× 160 0.5× 223 0.9× 158 0.7× 349 2.8× 42 912
Tsunehiro Ishida Japan 14 360 0.9× 175 0.5× 88 0.4× 86 0.4× 100 0.8× 52 650
Caroline Seynaeve Netherlands 16 570 1.5× 378 1.1× 353 1.5× 190 0.9× 222 1.8× 24 1.1k
John L. Hayward United Kingdom 15 383 1.0× 310 0.9× 207 0.9× 132 0.6× 105 0.8× 20 733
N Raverdy France 16 643 1.6× 116 0.3× 230 1.0× 85 0.4× 294 2.3× 36 1.1k
Jørn Andersen Denmark 20 461 1.2× 285 0.9× 107 0.4× 181 0.8× 267 2.1× 36 1.0k

Countries citing papers authored by A. Robinson

Since Specialization
Citations

This map shows the geographic impact of A. Robinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Robinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Robinson more than expected).

Fields of papers citing papers by A. Robinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Robinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Robinson. The network helps show where A. Robinson may publish in the future.

Co-authorship network of co-authors of A. Robinson

This figure shows the co-authorship network connecting the top 25 collaborators of A. Robinson. A scholar is included among the top collaborators of A. Robinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Robinson. A. Robinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mates, Mihaela, Philippe L. Bédard, John Hilton, et al.. (2021). 38MO IND.236: A Canadian Cancer Trial Group (CCTG) phase Ib trial of combined CFI-402257 and weekly paclitaxel (Px) in patients with HER2-negative (HER2-) advanced breast cancer (BC). Annals of Oncology. 32. S16–S16. 2 indexed citations
2.
Bédard, Philippe L., Mihaela Mates, Karen A. Gelmon, et al.. (2020). 19O A phase Ib trial of CFI-402257 in combination with weekly paclitaxel in patients with advanced HER2-negative (HER2-) breast cancer (aBC). Annals of Oncology. 31. S7–S7. 4 indexed citations
3.
Leonard, Robert, Rachel Ballinger, David Cameron, et al.. (2011). Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?. British Journal of Cancer. 105(9). 1260–1266. 33 indexed citations
4.
Tipples, Karen & A. Robinson. (2011). Optimal Management of Cancer Treatment-Induced Bone Loss. Drugs & Aging. 28(11). 867–883. 9 indexed citations
5.
Eminowicz, Gemma, et al.. (2011). Solitary atrial metastases: a rare clinical challenge. BMJ Case Reports. 2011. bcr1120103506–bcr1120103506. 2 indexed citations
6.
Tipples, Karen & A. Robinson. (2008). Optimising Care of Elderly Breast Cancer Patients: a Challenging Priority. Clinical Oncology. 21(2). 118–130. 8 indexed citations
7.
Sydes, Matthew R., J. Glaholm, Ruth E. Langley, et al.. (2007). Oral Sodium Clodronate for Nonmetastatic Prostate Cancer--Results of a Randomized Double-Blind Placebo-Controlled Trial: Medical Research Council PR04 (ISRCTN61384873). JNCI Journal of the National Cancer Institute. 99(10). 765–776. 83 indexed citations
8.
9.
Oliver, R.T.D., J. Ong, Jonathan Shamash, et al.. (2004). long-term follow-up of anglian germ cell cancer group surveillance versus patients with stage 1 nonseminoma treated with adjuvant chemotherapy. Urology. 63(3). 556–561. 67 indexed citations
10.
11.
Braun, Michael, F. Adab, C. R. Bradley, et al.. (2003). Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer. British Journal of Cancer. 89(7). 1155–1158. 13 indexed citations
12.
O’Farrell, Nigel & A. Robinson. (1998). Increasing Incidence of Genital Ulcer Disease in Durban, South Africa. 1 indexed citations
13.
Cantwell, B.M.J., et al.. (1992). A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer. British Journal of Cancer. 65(4). 621–623. 23 indexed citations
14.
Chan, Siew F, A. Robinson, & Richard J. Johnson. (1990). Percutaneous nephrostomy: Its value in obstructive uropathy complicating carcinoma of cervix uterus. Clinical Oncology. 2(3). 156–158. 7 indexed citations
15.
Robinson, A., et al.. (1989). Circulating reproductive hormones and hypothalamic oestradiol and progestin receptors in infertile Zucker rats. Journal of Endocrinology. 120(2). 331–336. 5 indexed citations
16.
Robinson, A. & William G. Jones. (1989). Changes in scalp hair after cancer chemotherapy. European Journal of Cancer and Clinical Oncology. 25(1). 155–156. 12 indexed citations
17.
Robinson, A., et al.. (1989). Bilateral carotid body tumours. The Journal of Laryngology & Otology. 103(5). 543–544. 1 indexed citations
18.
Robinson, A., et al.. (1988). THYROID FUNCTION IN MALE ZUCKER RATS EXPOSED TO COLD. Quarterly Journal of Experimental Physiology. 73(6). 1029–1031. 3 indexed citations
19.
Robinson, A., et al.. (1986). The teenager's swollen neck. British Journal of Radiology. 59(707). 1127–1128. 1 indexed citations
20.
Prendiville, Julie, A. Robinson, & Martin A. Young. (1982). Familial sarcoidosis. Irish Journal of Medical Science (1971 -). 151(1). 258–260. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Matthias Geberth Breakdown of academic impact, for papers by F Hofbauer Breakdown of academic impact, for papers by D F Hayes Breakdown of academic impact, for papers by I. D. Werner Breakdown of academic impact, for papers by C. Parsons Breakdown of academic impact, for papers by Tsunehiro Ishida Breakdown of academic impact, for papers by Caroline Seynaeve Breakdown of academic impact, for papers by John L. Hayward Breakdown of academic impact, for papers by N Raverdy Breakdown of academic impact, for papers by Jørn Andersen
Rankless by CCL
2026